当前位置:首页 > 关于我们 > 创投导师 > ​郑鑫

​郑鑫 | Zheng Xin


4.jpg

郑鑫

博士现任杭州道合天孚生物科技有限公司总经理,从事肝胆创新诊断研发。2007年开始从事物信息研究,专注于新兴测序技术在癌症/传染病领域的应数据信息挖掘。先后供职于美国Fort. Detrick肿瘤研究国家实验室和夏威夷学癌症中,以精深的专业素质和敬业精神,主导、参与了多个型研究项的设计和实施。2015年回国致于肿瘤诊断治疗创新法的研发,基于基因组和肿瘤临床据,开发肝胆肿瘤的新型诊断技术和治疗法,具有定的临床应;在新型冠状肺炎爆发后,首先发现并报道了相关病毒ORF8区域的溯源和防控意义。


Zheng Xin

PHD, General manager of Hangzhou Daohe Tianfu Biotechnology Co., Ltd. engaged in the research and development of Innovative Diagnosis of liver and gallbladder. Since 2007, he has been engaged in the research of biological information, focusing on the application of emerging sequencing technology in the field of cancer/infectious diseases and data information mining. He has successively worked in Fort Detrick National Laboratory of cancer research and Hawaii Cancer Center, led and participated in the design and implementation of a number of research projects.


0.188813s